Breaking News Instant updates and real-time market news.

NCS

NCI Building

$20.70

0.15 (0.73%)

18:27
07/17/18
07/17
18:27
07/17/18
18:27

NCI Building Systems, Ply Gem Parent to combine in stock-for-stock merger

NCI Building Systems and Ply Gem Parent, LLC, a manufacturer of exterior building products for residential construction, announced that they have signed a definitive agreement under which the two companies will combine in a stock-for-stock merger. The combined company will have a pro forma enterprise value of $5.5B and an implied equity value of $2.6B, based on NCI's closing share price on July 17, 2018. Under the terms of the agreement, NCI will issue 58.7 million shares to Ply Gem shareholders. Upon the close of the transaction, NCI shareholders will own 53% of the Company's common equity, with Ply Gem shareholders owning 47%. The transaction is generally expected to be tax-free to the Ply Gem owners for U.S. federal income tax purposes. On a combined basis for calendar year 2018, the company is expected to generate revenue of approximately $4.5B and Pro Forma Adjusted EBITDA of $660M-$680M, including run-rate synergies and cost savings. The company expects that, after three years following close, cost reduction initiatives and merger-related synergies will yield over $150M in annual cost savings. Clearly scoped standalone cost reduction initiatives are already well underway at both NCI and Ply Gem. Combination-specific synergies include manufacturing efficiencies and procurement and general & administrative savings. The transaction is expected to be immediately accretive to adjusted cash earnings per share and free cash flow. The transaction has been unanimously approved by a special committee of independent directors formed by NCI's Board of Directors and by NCI's full Board. The transaction is expected to close in the fourth calendar quarter of 2018, subject to approval by NCI shareholders and customary regulatory approvals.

NCS NCI Building
$20.70

0.15 (0.73%)

09/08/17
LEHM
09/08/17
NO CHANGE
Target $16
LEHM
Overweight
NCI Building post-earnings selloff yesterday 'too severe,' says Barclays
Barclays analyst Michael Dahl lowered his price target for NCI Building Systems to $16 from $19 but calls yesterday's post-earnings selloff "too severe." Yesterday's 21% pullback was "too harsh" given where estimates moved, Dahl tells investors in a research note. NCI Building remains a "strong earnings growth story" supported by internal margin initiatives, trading at an attractive valuation, the analyst contends. He keeps an Overweight rating on the shares.
12/08/17
DADA
12/08/17
NO CHANGE
Target $18
DADA
Neutral
NCI Building price target raised to $18 from $15 at DA Davidson
DA Davidson analyst Brent Thielman raised his price target on NCI Building to $18 after Q4 earnings. Thielman says the results continue to show modest growth in "low-to-mid rise building market-focused business" despite the hurricane-related headwinds observed mainly in the Engineering Building Systems. The analyst is also positive on the progress around cost controls supporting the case for the company to return to peak margin levels. Thielman keeps his Neutral rating, saying share price upside is contained in the absence of "more immediate growth catalysts".
06/07/18
LEHM
06/07/18
NO CHANGE
Target $24
LEHM
Overweight
NCI Building price target raised to $24 from $21 at Barclays
Barclays analyst Matthew Bouley raised his price target for NCI Building Systems to $24 saying a margin inflection is now in sight following the company's Q2 results. The analyst expects NCI to reach the awaited inflection point in margin performance in Q3 and he forecasts accelerating incrementals in Q4 and into 2019. Bouley keeps an Overweight rating on NCI Building.

TODAY'S FREE FLY STORIES

SITO

Sito Mobile

$1.12

0.1462 (15.01%)

16:38
11/15/18
11/15
16:38
11/15/18
16:38
Earnings
Sito Mobile reports Q3 EPS (20c) vs (14c) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

LHCG

LHC Group

$96.20

3.08 (3.31%)

16:38
11/15/18
11/15
16:38
11/15/18
16:38
Initiation
LHC Group initiated  »

LHC Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

REDU

Rise Education

$10.20

-0.22 (-2.11%)

16:38
11/15/18
11/15
16:38
11/15/18
16:38
Hot Stocks
Rise Education announces $30M share repurchase program »

Rise Education's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EHC

Encompass Health

$72.31

0.81 (1.13%)

16:37
11/15/18
11/15
16:37
11/15/18
16:37
Initiation
Encompass Health initiated  »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

HTHT

Huazhu Group

$28.59

0.64 (2.29%)

16:37
11/15/18
11/15
16:37
11/15/18
16:37
Earnings
Huazhu Group sees FY18 revenue growth at high end of 18%-22% range »

Consensus $1.42B. In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

UHS

Universal Health

$127.90

0.61 (0.48%)

16:36
11/15/18
11/15
16:36
11/15/18
16:36
Initiation
Universal Health initiated  »

Universal Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHT

Huazhu Group

$28.59

0.64 (2.29%)

16:36
11/15/18
11/15
16:36
11/15/18
16:36
Earnings
Breaking Earnings news story on Huazhu Group »

Huazhu Group sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

HTHT

Huazhu Group

$28.59

0.64 (2.29%)

16:36
11/15/18
11/15
16:36
11/15/18
16:36
Earnings
Huazhu Group reports Q3 adjusted EPS 24c, one estimate 27c »

Reports Q3 revenue $403M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

REDU

Rise Education

$10.20

-0.22 (-2.11%)

16:35
11/15/18
11/15
16:35
11/15/18
16:35
Earnings
Rise Education reports Q3 EPS 9c, two estimates 12c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

PEP

PepsiCo

$116.81

0.14 (0.12%)

16:35
11/15/18
11/15
16:35
11/15/18
16:35
Hot Stocks
PepsiCo maintains 92.75c per share dividend »

This dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Feb

16:34
11/15/18
11/15
16:34
11/15/18
16:34
General news
Money Supply M2 Weekly Change data reported »

Week of 11/5 Money Supply…

16:34
11/15/18
11/15
16:34
11/15/18
16:34
General news
Fed Balance Sheet Level data reported »

Week of 11/14 Fed Balance…

AMH

American Homes 4 Rent

$19.87

-0.42 (-2.07%)

16:34
11/15/18
11/15
16:34
11/15/18
16:34
Downgrade
American Homes 4 Rent rating change  »

American Homes 4 Rent cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNVR

Univar

$23.10

0.07 (0.30%)

16:34
11/15/18
11/15
16:34
11/15/18
16:34
Hot Stocks
Univar, Buckman reach distribution pact for U.S., Canada »

Univar announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$53.28

0.67 (1.27%)

16:33
11/15/18
11/15
16:33
11/15/18
16:33
Hot Stocks
Bristol-Myers receives positive CHMP opinion recommending Opdivo plus Yervoy »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

KAMN

Kaman

$57.82

0.41 (0.71%)

16:32
11/15/18
11/15
16:32
11/15/18
16:32
Hot Stocks
Kaman awarded $52M addition to Option 14 of its USAF JPF order »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$99.62

-1.96 (-1.93%)

, CSCO

Cisco

$46.77

2.42 (5.46%)

16:32
11/15/18
11/15
16:32
11/15/18
16:32
OnTheFly
Fly Intel: Wall Street's top stories for Thursday »

Stocks opened in negative…

WMT

Walmart

$99.62

-1.96 (-1.93%)

CSCO

Cisco

$46.77

2.42 (5.46%)

FB

Facebook

$143.86

-0.39 (-0.27%)

QURE

uniQure

$31.00

8.21 (36.02%)

ORCL

Oracle

$50.64

1.8 (3.69%)

BRK.A

Berkshire Hathaway

$325,810.00

1410 (0.43%)

PCG

PG&E

$17.77

-7.89 (-30.75%)

DDS

Dillard's

$62.62

-11.01 (-14.95%)

NTAP

NetApp

$68.84

-9.21 (-11.80%)

BRK.B

Berkshire Hathaway

$217.49

1.465 (0.68%)

RYB

RYB Education

$7.82

-8.99 (-53.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 26

    Nov

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

  • 10

    Jan

INTC

Intel

$48.12

1.03 (2.19%)

16:31
11/15/18
11/15
16:31
11/15/18
16:31
Hot Stocks
Intel board approves $15B increase in authorized stock repurchase program »

Intel Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

TGT

Target

$80.76

-2.35 (-2.83%)

16:31
11/15/18
11/15
16:31
11/15/18
16:31
Initiation
Target initiated  »

Target initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Hot Stocks
Nvidia board authorizes additional $7B under share buyback program »

In November 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

LTRX

Lantronix

$3.51

0.03 (0.86%)

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Syndicate
Breaking Syndicate news story on Lantronix »

Lantronix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Hot Stocks
Nvidia raises quarterly dividend 7% to 16c per share »

Nvidia announced a 7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

16:30
11/15/18
11/15
16:30
11/15/18
16:30
Options
Preliminary option volume of 24.1M today »

Preliminary option volume…

GOGL

Golden Ocean

$6.68

0.19 (2.93%)

, SALT

Scorpio Bulkers

$5.71

0.115 (2.06%)

16:29
11/15/18
11/15
16:29
11/15/18
16:29
Initiation
Golden Ocean, Scorpio Bulkers initiated  »

Golden Ocean, Scorpio…

GOGL

Golden Ocean

$6.68

0.19 (2.93%)

SALT

Scorpio Bulkers

$5.71

0.115 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

16:28
11/15/18
11/15
16:28
11/15/18
16:28
Earnings
Nvidia sees Q4 revenue $2.7B, +/- 2%, consensus $3.4B »

GAAP and non-GAAP gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.